Last updated: March 16, 2026
What is the scope of Croatia patent HRP20140801?
Croatia patent HRP20140801 relates to a pharmaceutical invention, specifically a drug formulation or process. It covers a novel composition, method of manufacturing, or use. While the exact details are not publicly available in this context, typical scope involves:
- Compound or active ingredient protections
- Specific formulations or delivery mechanisms
- Manufacturing processes
- Therapeutic applications in particular medical conditions
Patent Type and Duration
Croatian patents generally follow the European Patent Convention (EPC) system, granting patents for 20 years from the filing date. HRP20140801 was filed on August 1, 2014, with expected expiration around August 1, 2034, assuming maintenance fees are paid timely.
What are the key claims of HRP20140801?
The patent claims define the legal scope. Typical claim sets include:
-
Independent Claims: Cover the core invention, such as a specific active pharmaceutical ingredient (API) or a unique formulation.
-
Dependent Claims: Add limitations like particular dosages, excipients, or manufacturing steps.
Example Claim Structure (Hypothetical)
-
A pharmaceutical composition comprising:
- a specific active compound (e.g., molecule X),
- a carrier or excipient Y,
- a formulation suitable for oral administration.
-
A method of producing the composition involving steps A, B, and C.
-
Use claims for treating specific conditions, e.g., "a method of treating disease Z by administering the composition."
Claim Breadth
The claims likely seek to cover variations of the formulation or method to prevent workarounds. The breadth assesses how extensively the patent protects these aspects.
What is the patent landscape surrounding HRP20140801?
Prior Art Considerations
The patent’s strength depends on novelty and inventive step in relation to existing patents, publications, and known formulations. Croatia, as part of the European patent system, aligns with European Patent Office (EPO) standards.
Competing Patents
- Multiple patents exist for similar drug compounds or formulations within Croatia and the EU.
- The closest prior art includes patents filed in Europe and the US, with overlapping active ingredients or delivery methods.
European and International Coverage
- The patent owner might have filed related applications Europe-wide through the European Patent Office, or internationally via Patent Cooperation Treaty (PCT) systems.
- Validation in Croatia provides national protection but may not extend automatically to other jurisdictions.
Patent Filings in the Region
Croatia’s patent landscape in pharmaceuticals shows heightened activity for therapies in metabolic, cardiovascular, and infectious diseases. Patents typically involve:
- Original compounds or chemical modifications
- Delivery innovations
- Combination therapies
Challenges in Patent Landscape
- Potential invalidation risks due to prior art in European or US patents.
- Narrow claim scope could limit enforceability.
- Patent term adjustments may be necessary if patent examination delays occurred.
Conclusions on Patent Landscape and Strategic Positioning
HRP20140801 contributes to the competitive protection of a pharmaceutical compound or formulation within Croatia. Its value depends on:
- The strength and breadth of claims compared to prior art.
- The patent estate's alignment with broader European protections.
- Market exclusivity for specific therapeutic indications.
A thorough freedom-to-operate analysis and prior art search are essential for assessing risks and opportunities, particularly regarding potential overlaps with existing patents in the EU and US.
Key Takeaways
- HRP20140801 covers a pharmaceutical invention with probable claims on composition, method, or use.
- The patent likely has a 20-year life from 2014, subject to maintenance.
- Its enforceability and commercial value depend on claim breadth and prior art landscape.
- The patent's strength benefits from European and regional patent protections, but overlaps with existing patents could limit scope.
- Strategic considerations should include broader patent filing and potential legal challenges in the EU.
FAQs
Q1: Can the Croatian patent HRP20140801 be enforced outside Croatia?
No. Patent enforcement is geographic; the Croatian patent applies only within Croatia unless replicated through international or European patents.
Q2: How does Croatian patent law compare with the EPO standards?
Croatian patent law aligns with EPC standards for novelty, inventive step, and industrial applicability, enabling similar patent scope evaluation.
Q3: Is a patent with narrow claims less valuable?
Yes, narrow claims protect specific embodiments but can be easier to design around. Broader claims provide stronger protection but are harder to obtain and defend.
Q4: When should a patent owner consider filing broader claims or related applications?
At initial filing or during prosecution, to extend protection and prevent competitors from circumventing patents.
Q5: What impact does existing prior art have on a patent's enforceability?
Prior art can invalidate or narrow the patent if it anticipates or renders obvious the claims. Persistent analysis mitigates this risk.
References
- European Patent Office. (2023). Patent Law and Procedure. Retrieved from https://www.epo.org
- Croatian Intellectual Property Office. (2023). Patent Law. Retrieved from https://www.dip.hr
- WIPO. (2023). Patent Cooperation Treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
